Humana Inc (HUM) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.022x

Based on the latest financial reports, Humana Inc (HUM) has a cash flow conversion efficiency ratio of -0.022x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-426.00 Million) by net assets ($19.28 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Humana Inc (HUM) total market value for the company's overall valuation and market capitalisation.

Humana Inc - Cash Flow Conversion Efficiency Trend (1990–2025)

This chart illustrates how Humana Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Humana Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humana Inc ranked by their cash flow conversion efficiency. Explore Humana Inc cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
BASF SE
XETRA:BAS
0.014x
Samsung Biologics Co Ltd
KO:207940
0.075x
Ferguson Plc
NYSE:FERG
0.131x
Shanghai Pudong Development Bank Co Ltd
SHG:600000
0.109x
AngloGold Ashanti Ltd
JSE:ANG
0.133x
CTBC Financial Holding Co Ltd
TW:2891
0.246x
Coca-Cola European Partners PLC
NASDAQ:CCEP
0.116x
Hangzhou Hikvision Digital Technology Co Ltd
SHE:002415
0.089x

Annual Cash Flow Conversion Efficiency for Humana Inc (1990–2025)

The table below shows the annual cash flow conversion efficiency of Humana Inc from 1990 to 2025. View HUM stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $17.74 Billion $921.00 Million 0.052x -71.21%
2024-12-31 $16.45 Billion $2.97 Billion 0.180x -26.07%
2023-12-31 $16.32 Billion $3.98 Billion 0.244x -18.25%
2022-12-31 $15.37 Billion $4.59 Billion 0.298x +112.46%
2021-12-31 $16.10 Billion $2.26 Billion 0.140x -65.80%
2020-12-31 $13.73 Billion $5.64 Billion 0.411x -6.43%
2019-12-31 $12.04 Billion $5.28 Billion 0.439x +105.27%
2018-12-31 $10.16 Billion $2.17 Billion 0.214x -48.04%
2017-12-31 $9.84 Billion $4.05 Billion 0.412x +127.17%
2016-12-31 $10.69 Billion $1.94 Billion 0.181x +115.97%
2015-12-31 $10.35 Billion $868.00 Million 0.084x -49.98%
2014-12-31 $9.65 Billion $1.62 Billion 0.168x -8.94%
2013-12-31 $9.32 Billion $1.72 Billion 0.184x -15.26%
2012-12-31 $8.85 Billion $1.92 Billion 0.217x -15.70%
2011-12-31 $8.06 Billion $2.08 Billion 0.258x -20.36%
2010-12-31 $6.92 Billion $2.24 Billion 0.324x +31.55%
2009-12-31 $5.78 Billion $1.42 Billion 0.246x +11.68%
2008-12-31 $4.46 Billion $982.31 Million 0.220x -27.47%
2007-12-31 $4.03 Billion $1.22 Billion 0.304x -44.98%
2006-12-31 $3.05 Billion $1.69 Billion 0.552x +118.42%
2005-12-31 $2.47 Billion $625.63 Million 0.253x +51.96%
2004-12-31 $2.09 Billion $347.81 Million 0.166x -26.05%
2003-12-31 $1.84 Billion $413.14 Million 0.225x +12.47%
2002-12-31 $1.61 Billion $321.41 Million 0.200x +102.54%
2001-12-31 $1.51 Billion $148.96 Million 0.099x +235.86%
2000-12-31 $1.36 Billion $40.00 Million 0.029x -83.51%
1999-12-31 $1.22 Billion $217.00 Million 0.178x +296.22%
1998-12-31 $1.69 Billion $76.00 Million 0.045x -79.45%
1997-12-31 $1.32 Billion $289.00 Million 0.219x -16.98%
1996-12-31 $1.29 Billion $341.00 Million 0.264x +126.45%
1995-12-31 $1.29 Billion $150.00 Million 0.117x -58.62%
1994-12-31 $1.06 Billion $298.00 Million 0.282x +35.35%
1993-12-31 $889.00 Million $185.00 Million 0.208x -37.76%
1992-12-31 $2.02 Billion $674.00 Million 0.334x +11.20%
1991-12-31 $2.01 Billion $604.00 Million 0.301x -30.63%
1990-12-31 $1.75 Billion $758.30 Million 0.433x --

About Humana Inc

NYSE:HUM USA Healthcare Plans
Market Cap
$46.20 Billion
Market Cap Rank
#626 Global
#306 in USA
Share Price
$384.72
Change (1 day)
-3.00%
52-Week Range
$163.67 - $409.80
All Time High
$553.59
About

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medic… Read more